USPTO serial 97015504
PROTEUS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHUNG, DIANA ALANA
- Law office
- TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PROTEUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Otsuka Pharmaceutical Co., Ltd.
Chiyoda-ku, Tokyo,, JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott S. Havlick
Scott S. Havlick HOLLAND & HART LLPP.O. BOX 8749ATTN: TRADEMARK DOCKETINGDENVER, CO 80201Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Ingestible medications and pharmaceutical preparations, both prescription and over-the-counter, and placebo pill preparations for medical use containing an ingestible sensor for use in connection with humans and animals to facilitate in the provision of data related to the patient including patient physiologic data, patient environment, treatment data, data related to medications, pharmaceuticals, and supplements, and data transmitted by medical devices for the purpose of maximizing patient outcome in the diagnosis, treatment, and management of cancers, chronic pain, skin disease, diseases of the ear, nose, and throat, infectious diseases, psychiatric disorders, and diseases of the cardiovascular, respiratory, metabolic, immune, central nervous, endocrine, glandular, musculoskeletal, digestive, excretory, and reproductive systems; dietary and nutritional supplements containing an ingestible sensor for use in connection with humans and animals to facilitate in the provision of data related to the patient, patient environment and the supplement | ACTIVE | — |
| 009 | Semiconductors, Semiconductor chips, Semiconductor devices, Semiconductor power elements; computer software for processing physiologic data, environmental data, patient treatment data, data related to efficacy of medications, pharmaceuticals and supplements, and patient data transmitted by medical devices, ingestible sensors, implants, and conductive packaging and labels; wireless electronic devices using wireless personal area network technology, namely, wireless receivers and transmitters that can be worn, implanted, held, integrated in to a case for mobile phones and tablet computers or otherwise configured to communicate while in physical contact with a human or animal; downloadable computer software to store, report, monitor, upload, and download information and data on patient status and condition, response and adherence to treatment regimens, efficacy of treatment, to track and report on physiologic data, environmental data, treatment data, data related to medications, pharmaceuticals and supplements, and data transmitted by medical devices, ingestible sensors, implants, and conductive packaging and labels, to track and monitor nutrition, calories, health, fitness, personal exercise, sports, and athletic activity, information and achievements, identifying trends in the uploaded information and data, correlating adherence to treatment regimens with wellness metrics, establishing and tracking personal health and fitness goals, providing positive reinforcement and sending personalized notifications and reminders; data central processing units for processing pharmaceutical or device compliance data, pharmaceutical administration data, device activation data or physiological response data; database computer software for use with medical devices for monitoring administration of pharmaceutical compositions, device activation or physiological responses | ACTIVE | — |
| 010 | Non-implantable and portable medical and diagnostic devices, namely, patient monitors and wearable patient monitor patches and ingestible patient sensors for monitoring, measuring and capturing physiologic data, environmental data, treatment data, data related to medications, pharmaceuticals, and supplements, and data transmitted by medical devices; medical devices, namely, wireless receivers and transmitters used for capturing patient physiologic data, patient environmental data, patient treatment data, data related to patient medications, pharmaceuticals, and supplements, and patient data transmitted by medical devices, ingestible sensors, implants, and conductive packaging and labels; medical monitoring devices for use in the administration of pharmaceutical compositions | ACTIVE | — |
| 042 | Providing temporary use of non-downloadable computer software to store, report, monitor, upload, and download information and data on patient status and condition, response and adherence to treatment regimens, efficacy of treatment, to track and report on physiologic data, environmental data, treatment data, data related to medications, pharmaceuticals and supplements, and data transmitted by medical devices, ingestible sensors, implants, and conductive packaging and labels, to track and monitor nutrition, calories, health, fitness, personal exercise, sports, and athletic activity, information and achievements, identifying trends in the uploaded information and data, correlating adherence to treatment regimens with wellness metrics, establishing and tracking personal health and fitness goals, providing positive reinforcement and sending personalized notifications and reminders; computer services, namely, creating an on-line community for registered users to participate in discussions, get feedback from their peers, form virtual communities, and engage in social networking services in the field of health, nutrition, fitness and wellness; computer services, namely, providing secure electronic data storage, backup, and archiving services for electronic data, files, documents, images and other digital electronic data content; medical research in the field of medical and surgical apparatus, appliances, instruments, therapies and drugs | ACTIVE | — |
| 044 | Providing advice and information regarding medical disorders, health, wellness and nutrition; providing a website featuring information to patients in the field of administering medication, and information regarding medical disorders, health, wellness and nutrition; providing an Internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processed, exchanged and accessed in real-time by users; providing a website featuring information about health, wellness and nutrition, featuring advice and tracking personal statistics regarding health, wellness and nutrition goals; providing health and medical information about medical disorders; information services, namely, providing medical information to chronically ill patients; information services relating to medical services via a global computer network, namely, providing medical consultancy and advisory services via a global computer network | ACTIVE | — |
| 045 | Online social networking services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named PROTEUS
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 6, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 6, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 21, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 6, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 3, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 3, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 3, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 20, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 14, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 14, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 14, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 13, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 12, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 12, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 26, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 25, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 18, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 10, 2021 | NWAP | NEW APPLICATION ENTERED | — |